Anatara Lifesciences (ASX:ANR) CEO Steve Lydeamore recently spoke with experienced business writer, Tim Boreham, for his Dr Boreham's Crucible column which was published in Biotech Daily on Friday night and then reproduced in Stockhead across the weekend.
The 2018-2019 year has been a year of transition for Anatara Lifesciences (ASX:ANR), having commenced the year with a clear focus on successfully evolving into a human health company, through the pursuit of the burgeoning gastrointestinal health market.
THC Global Group Limited (ASX:THC) (FRA:9TH) (OTCMKTS:HDRPF) is pleased to advise that yesterday, THC Global's Southport Facility was opened by the Federal Minister for Health, The Honourable Greg Hunt MP, following a tour of the Facility earlier in the day.
The Board of Cann Global Limited (ASX:CGB) is pleased to announce that its T12 Food Division, under managers Sebastian and Samuel Edwards, has become an official supplier to Costco.
Anatara Lifesciences (ASX:ANR) today released its Appendix 4E and review of operations for the period ending 30th June 2019.
Cann Global Limited (ASX:CGB) provides the following update in relation to CGB's Nutraceutical manufacturing schedule and the Israeli based Pharmocann formulator's visit to Australia.
Anatara Lifesciences (ASX:ANR) is pleased to release to investors a copy of the presentation that Chief Executive Officer, Mr Steven Lydeamore, presented at the Monsoon Communications Twilight Investor Briefing, yesterday evening, in Melbourne.
